Gohealth

GOCO · NASDAQ

Price unavailable right now.

No price history for this range.

About GOCO

GoHealth, Inc. is a digital health company, which engages in the provision of insurance services. The company is headquartered in Chicago, Illinois and currently employs 850 full-time employees. The company went IPO on 2020-07-15. The firm primarily offers Medicare plans, including Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms, powered by insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer’s specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. The company offers Encompass Connect and Encompass Engage services to its health plan partners.

Employees
850
Headquarters
Chicago, Illinois
Listed
Jul 15, 2020
Sector
Financials
Industry
Insurance

GOCO key statistics

This section is temporarily unavailable. Refresh to try again.

Analyst ratings

Latest rating from each analyst over the past 12 months

33%of 3 analyst ratings say Buy
  • Buy33.3%
  • Hold66.7%
  • Sell0.0%
Price target · 4 analystsAvg $5.86
Low
$1.51
High
$10.50

GOCO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 98.0% on average.

  1. Q2 FY24: reported -$2.70 per share against an estimate of -$2.52
  2. Q3 FY24: reported $0.46 per share against an estimate of -$3.25
  3. Q4 FY24: reported $2.19 per share against an estimate of $1.19
  4. Q1 FY25: reported -$0.52 per share against an estimate of -$0.2999
  5. Q2 FY25: reported -$0.12 per share against an estimate of -$2.63
  6. Q3 FY25: reported -$11.80 per share against an estimate of -$2.06
  7. Q4 FY25: reported -$1.98 per share against an estimate of -$1.14
  8. Q1 FY26: reported -$2.36 per share against an estimate of -$2.02

GOCO news

  • Caroline Ryan

    Deal Dispatch: Carlyle Buys Chung Ho Group, Second Nature Brands Acquires Tillamook Country Smoker, GoHealth Bankruptcy

  • Avi Kapoor

    Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings

  • Avi Kapoor

    Nasdaq Jumps Over 200 Points; Campbell's Posts Upbeat Q3 Earnings

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth Inc. - GOCO

  • Preview: GoHealth's Earnings

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, and Cleveland-Cliffs and Encourages Investors to Contact the Firm

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm

  • Press releasePRNewswire

    Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation - GOCO

Similar companies

Companies in the same industry as Gohealth

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.